Floatz logo

Carisbamate

Epilepsy, Simple Partial

SK Life Science, Inc.Small moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Epilepsy, Simple Partial cohort.

Asset / SponsorPhaseRating
Fycompa
Chinese University of Hong Kong
NR
Remegal
Valexfarm
Phase 3NR

Same molecule, other indications

Carisbamate is also rated in:

complex partial epilepsyDormant
BB
Indicative ·
71 / 100
View asset →
partial motor epilepsyDormant
BB
Indicative ·
68 / 100
View asset →
Lennox-Gastaut syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →